How much funding has Mammoth Biosciences raised?

Mammoth Biosciences has raised $263.0M in total funding, most recently a Series D round.

Who are Mammoth Biosciences's investors?

Mammoth Biosciences's investors include Redmile Group, Decheng Capital, Mayfield Fund, Foresite Capital, Senator Investment Group, Sixth Street.

When was Mammoth Biosciences founded?

Mammoth Biosciences was founded in 2017.

Where is Mammoth Biosciences headquartered?

Mammoth Biosciences is headquartered in Brisbane, California, United States.

What industry is Mammoth Biosciences in?

Mammoth Biosciences operates in Biotech.

How many employees does Mammoth Biosciences have?

Mammoth Biosciences has 51-200 employees.

Mammoth Biosciences

Reading and writing the code of life

Brisbane, United States · Founded 2017 · $263.0M raised

Biotech

Headquarters: Brisbane, California
Employees: 51–200
Founded: 2017
Business Model: B2B

Website: mammoth.bio
Total Funding: $263.0M
Last Round: $150.0M Series DSep 2021
Rounds: 4

About

Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop potential long-term curative therapies for patients with life-threatening and debilitating diseases. The company has partnerships with Regeneron and Vertex.

Summary

Mammoth Biosciences is a Biotech company based in Brisbane, United States, founded in 2017. It has raised $263.0M in total across 4 rounds, most recently a $150.0M Series D round in Sep 2021. Investors include Redmile Group, Decheng Capital and Mayfield Fund.

LinkedIn X (Twitter)